PTEN/MMACl expression in melanoma resection specimens

被引:27
作者
Deichmann, M
Thome, M
Benner, A
Egner, U
Hartschuh, W
Näher, H
机构
[1] Univ Clin Heidelberg, Dept Dermatol, D-69115 Heidelberg, Germany
[2] German Canc Res Ctr RO700, Cent Unit Biostat, D-69120 Heidelberg, Germany
关键词
melanoma; PTEN/MMACl; tumour suppressor gene;
D O I
10.1038/sj.bjc.6600653
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PTEN/MMAC1, a tumour suppressor gene located on chromosome 10q23.3, has been found to be deleted in several types of human malignancies. As the chromosomal region 10q22-qter commonly is affected by losses in melanomas, we addressed this gene as tumour suppressor candidate in melanomas. Investigating PTEN/MMAC1 expression at mRNA level by semi-quantitative reverse transcription-polymerase chain reaction, we did not find a statistically significant down-regulation in melanoma resection specimens in comparison to acquired melanocytic new from which melanomas quite often are known to arise, Upon immunohistochemistry, PTEN/MMAC1 protein expression in melanomas was not lost. Sequencing the PTEN/ MMAC1 cDNAs in 26 melanoma resection specimens (21 primary melanomas, five metastases), we detected three point mutations and two nucleotide deletions which did not represent genetic polymorphisms. With respect to the predicted protein sequences, all three point mutations were silent whereas the two frame shifts at the extreme C-terminus resulted in a loss of the putative PDZ-targeting consensus sequence. As loss of this motif possibly impairs localization and function of PTEN/MMAC1 in the two corresponding primary tumours, alterations of this tumour suppressor protein may participate in some melanomas. (C) 2002 Cancer Research UK.
引用
收藏
页码:1431 / 1436
页数:6
相关论文
共 48 条
  • [11] Guldberg P, 1997, CANCER RES, V57, P3660
  • [12] Prognostic significance of allelic losses in primary melanoma
    Healy, E
    Belgaid, C
    Takata, M
    Harrison, D
    Zhu, NW
    Burd, DAR
    Rigby, HS
    Matthews, JNS
    Rees, JL
    [J]. ONCOGENE, 1998, 16 (17) : 2213 - 2218
  • [13] Healy E, 1996, CANCER RES, V56, P589
  • [14] PTEM and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo
    Herbst, RA
    Podewski, EK
    Mommert, S
    Kapp, A
    Weiss, J
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1999, 291 (10) : 567 - 569
  • [15] HERBST RA, 1994, CANCER RES, V54, P3111
  • [16] USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES
    HSU, SM
    RAINE, L
    FANGER, H
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) : 577 - 580
  • [17] COLOR MODIFICATION OF DIAMINOBENZIDINE (DAB) PRECIPITATION BY METALLIC-IONS AND ITS APPLICATION FOR DOUBLE IMMUNOHISTOCHEMISTRY
    HSU, SM
    SOBAN, E
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1982, 30 (10) : 1079 - 1082
  • [18] 10q deletions in metastatic cutaneous melanoma
    Indsto, JO
    Holland, EA
    Kefford, RF
    Mann, GJ
    [J]. CANCER GENETICS AND CYTOGENETICS, 1998, 100 (01) : 68 - 71
  • [19] CHROMOSOME 10 ALLELIC LOSS IN MALIGNANT-MELANOMA
    ISSHIKI, K
    ELDER, DE
    GUERRY, D
    LINNENBACH, AJ
    [J]. GENES CHROMOSOMES & CANCER, 1993, 8 (03) : 178 - 184
  • [20] Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions
    Leslie, NR
    Bennett, D
    Gray, A
    Pass, I
    Hoang-Xuan, K
    Downes, CP
    [J]. BIOCHEMICAL JOURNAL, 2001, 357 : 427 - 435